| Literature DB >> 25755977 |
Iqbal Ahmad1, Muhammad Ali Sheraz1, Sofia Ahmed1, Sadia Hafeez Kazi1, Tania Mirza1, Mohammad Aminuddin1.
Abstract
In the present investigation the photolysis of riboflavin (RF) in the presence of citrate species at pH 4.0-7.0 has been studied. A specific multicomponent spectrophotometric method has been used to assay RF in the presence of photoproducts during the reactions. The overall first-order rate constants (k obs ) for the photolysis of RF range from 0.42 to 1.08×10(-2) min(-1) in the region. The values of k obs have been found to decrease with an increase in citrate concentration indicating an inhibitory effect of these species on the rate of reaction. The second-order rate constants for the interaction of RF with total citrate species causing inhibition range from 1.79 to 5.65×10(-3) M(-1) min(-1) at pH 4.0-7.0. The log k-pH profiles for the reactions at 0.2-1.0 M citrate concentration show a gradual decrease in k obs and the value at 1.0 M is more than half compared to that of k 0, i.e., in the absence of buffer, at pH 5.0. Divalent citrate ions cause a decrease in RF fluorescence due to the quenching of the excited singlet state resulting in a decrease in the rate of reaction and consequently leading to the stabilization of RF solutions. The greater quenching of fluorescence at pH 4.0 compared to that of 7.0 is in accordance with the greater concentration of divalent citrate ions (99.6%) at that pH. The trivalent citrate ions exert a greater inhibitory effect on the rate of RF photolysis compared to that of the divalent citrate ions probably as a result of excited triplet state quenching. The values of second-order rate constants for the interaction of divalent and trivalent citrate ions are 0.44×10(-2) and 1.06×10(-3) M(-1) min(-1), respectively, indicating that the trivalent ions exert a greater stabilizing effect, compared to the divalent ions, on RF solutions.Entities:
Keywords: Citrate buffer; Fluorescence; Kinetics; Photolysis; Riboflavin; Spectrophotometric assay
Year: 2011 PMID: 25755977 PMCID: PMC4150622 DOI: 10.1016/j.rinphs.2011.06.002
Source DB: PubMed Journal: Results Pharma Sci ISSN: 2211-2863